Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
BriefNYTimes Health
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
BriefNYTimes Health
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.